Advertisement
Table 1 Characteristics of patients in the efficacy analysis group
| Characteristics of Patients | n (%) or mean ± SD |
|---|---|
| Number | 3316 |
| Entry category | |
| Type 1 diabetes, n/% | 40 (1.2%) |
| Type 2 diabetes, n/% | 3235 (97.6%) |
| Diabetes (diagnosis unknown), n/% | 37 (1.1%) |
| FBG ≥ 6.1 [mmol/l], n/% | 4 (0.1%) |
| Outpatients, n/% | 3212 (96.9%) |
| Men, n/% | 2074 (62.5%) |
| Age, mean/SD | 61.0 ± 12.0 |
| ≥65 yeas, n/% | 1400 (42.2%) |
| BMI (kg/m2), mean/SD | 25.7 ± 3.7 |
| Smoking, n/% | 825 (24.9%) |
| Alcohol consumption, n/% | 1129 (34.0%) |
| Complication, n/% | 2397 (72.3%) |
| Hepatic disease, n/% | 339 (10.2%) |
| Kidney disease, n/% | 51 (1.5%) |
| Hypertension, n/% | 1614 (48.7%) |
| Heart disease, n/% | 325 (9.8%) |
| Duration of hyperlipidemia (years), mean/SD | 4.7 ± 4.3 |
| Duration of diabetes (years), mean/SD | 6.6 ± 5.9 |
| Previous treatment of hyperlipidemia, n/% | 602 (18.2%) |
| Previous treatment of diabetes, n/% | 1977 (59.6%) |
| Total cholesterol (mmol/l), mean/SD | 5.76 ± 1.03 |
| LDL cholesterol (mmol/l), mean/SD | 3.19 ± 0.95 |
| HDL cholesterol (mmol/l), mean/SD | 1.18 ± 0.33 |
| TG (mmol/l), mean/SD | 3.72 ± 2.45 |
| HbA1c (%), mean/SD | 7.69 ± 1.52 |
| FBG (mmol/l), mean/SD | 9.01 ± 3.49 |
